CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Report for D009209: Myofascial Pain Syndromes NIH

(Synonyms: Myofasc, Myofascial, Myofascial, Myofascial Pain, Myofascial Pain Synd, Myofascial Pain Syndrom, Myofascial Pain Syndromes)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D005356 Fibromyalgia NIH 1.00

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Prevalence of Fibromyalgia in the Rheumatology Outpatient Clinics in the UAE During the COVID-19 Pandemic: a Cross-sectional Study

On 12 January 2020, the World Health Organization (WHO) confirmed that a novel coronavirus was the cause of a respiratory illness in a cluster of people in Wuhan City, Hubei Province, China, which was reported to the WHO on 31 December 2019. There is evidence of a high prevalence of psychiatric comorbidities in Fibromyalgia (FM )(especially depression, anxiety, post-traumatic stress disorder), which are associated with a worse clinical profile. In these challenging times of COVID-19, anxiety increased among the general population. Fibromyalgia patients are more at risk of developing anxiety in these difficult times. This might result in more frequent visits to the rheumatology clinics with an exacerbation of their chronic pain syndrome.

NCT04422522 Fibromyalgia, Primary
MeSH:Fibromyalgia Myofascial Pain Syndromes

Primary Outcomes

Description: Number of FM patients in the rheumatology outpatient clinics during the COVID-19 lockdown period (2020)

Measure: Number of FM patients

Time: two months

HPO Nodes